Literature DB >> 10902790

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

M Asunción1, R M Calvo, J L San Millán, J Sancho, S Avila, H F Escobar-Morreale.   

Abstract

We prospectively estimated the prevalence of the polycystic ovary syndrome (PCOS), as defined by the NIH/NICHHD 1990 endocrine criteria, in a population of 154 Caucasian women of reproductive age reporting spontaneously for blood donation. Anthropometric data; the presence of hirsutism, acne, and androgenic alopecia; and the menstrual history were recorded by a single investigator. In 145 women, blood samples were also obtained for measurement of serum androgen levels. PCOS was defined by the presence of 1) oligomenorrhea, 2) clinical and/or biochemical hyperandrogenism, and 3) exclusion of hyperprolactinemia, thyroid disorders, and nonclassic 21-hydroxylase deficiency. Hirsutism was defined by a modified Ferriman-Gallwey score of 8 or more, acne was considered as a sign of hyperandrogenism when persistent after the second decade of life, and hyperandrogenemia was defined by an increase in circulating testosterone or dehydroepiandrosterone sulfate or an increase in the free androgen index above the 95th percentile of the control values derived from the nonhirsute, nonacneic women having regular menses who were not receiving hormonal therapy. PCOS was present in 10(6.5%), hirsutism was present in 11 (7.1%), and acne was present in 19 (12.3%) of the 154 women. Our results demonstrate a 6.5% prevalence of PCOS, as defined, in a minimally biased population of Caucasian women from Spain. The polycystic ovary syndrome, hirsutism, and acne are common endocrine disorders in women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902790     DOI: 10.1210/jcem.85.7.6682

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  264 in total

1.  Euglena gracilis deoxyribonucleic acid polymerases: subcellular locations and variations during the cell cycle.

Authors:  A G McLennan; H M Keir
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

Review 2.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

3.  Histological evaluation of rat larynx in experimental polycystic ovary syndrome model.

Authors:  Hande Senem Deveci; Ildem Deveci; Mehmet Habesoglu; Mehmet Sürmeli; Vefa Kınıs; Murat Eriman; Pembegul Gunes; Murat Yekrek; Erol Egeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-11       Impact factor: 2.503

4.  The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.

Authors:  J R Palacio; A Iborra; Z Ulcova-Gallova; R Badia; P Martínez
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

5.  Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.

Authors:  M Möhlig; A Flöter; J Spranger; M O Weickert; T Schill; H W Schlösser; G Brabant; A F H Pfeiffer; J Selbig; C Schöfl
Journal:  Diabetologia       Date:  2006-09-14       Impact factor: 10.122

6.  Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome.

Authors:  Claudia Gagnon; Jean-Patrice Baillargeon
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

7.  Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

Authors:  Ying Liu; Mei-Guo Sun; Rong Jiang; Rui Ding; Zhen Che; Yan-Yan Chen; Ci-Jiang Yao; Xiao-Xia Zhu; Ji-Yu Cao
Journal:  J Assist Reprod Genet       Date:  2014-01-17       Impact factor: 3.412

Review 8.  Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Juan Pablo Domecq; Gabriela Prutsky; Rebecca J Mullan; Vishnu Sundaresh; Amy T Wang; Patricia J Erwin; Corrine Welt; David Ehrmann; Victor M Montori; Mohammad Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

9.  Relationship between polycystic ovary syndrome and ancestry in European Americans.

Authors:  Andrew C Bjonnes; Richa Saxena; Corrine K Welt
Journal:  Fertil Steril       Date:  2016-09-22       Impact factor: 7.329

10.  Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys.

Authors:  David H Abbott; Deborah K Barnett; Jon E Levine; Vasantha Padmanabhan; Daniel A Dumesic; Steve Jacoris; Alice F Tarantal
Journal:  Biol Reprod       Date:  2008-04-02       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.